Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Klaus Bister

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|December 9, 2015
Discovery of oncogenes: The advent of molecular cancer researchKlaus Bister
Methods in Molecular Biology (Clifton, N.J.)|September 6, 2013
Analyzing Myc in cell transformation and evolutionMarkus Hartl, Klaus Bister
Methods in Molecular Biology (Clifton, N.J.)|May 21, 2021
MYC Analysis in Cancer and EvolutionMarkus Hartl, Klaus Bister
Current Topics in Microbiology and Immunology|May 4, 2017
MYC and RAF: Key Effectors in Cellular Signaling and Major Drivers in Human CancerEduard Stefan, Klaus Bister
Advances in Protein Chemistry and Structural Biology|February 21, 2018
Targeting the Architecture of Deregulated Protein Complexes in CancerEduard Stefan, Jakob Troppmair, Klaus Bister
Aging|July 19, 2015
Stopping MYC in its tracksEduard Stefan, Jonathan R Hart, Klaus Bister
Small Gtpases|December 11, 2013
Interplay of PKA and Rac: fine-tuning of Rac localization and signalingVerena A Bachmann, Klaus Bister, Eduard Stefan
Bioconjugate Chemistry|December 24, 2013
Efficient access to 3'-terminal azide-modified RNA for inverse click-labeling patternsTobias Santner, Markus Hartl, Klaus Bister, et al.
Molecular Oncology|January 17, 2020
The brain acid-soluble protein 1 (BASP1) interferes with the oncogenic capacity of MYC and its binding to calmodulinMarkus Hartl, Kane Puglisi, Andrea Nist, et al.
Virology|July 8, 2008
TOJ3, a v-jun target with intrinsic oncogenic potential, is directly regulated by Jun via a novel AP-1 binding motifAntonios I Karagiannidis, Andreas G Bader, Markus Hartl, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Proceedings of the National Academy of Sciences of the United States of America|December 9, 2015
Discovery of oncogenes: The advent of molecular cancer researchKlaus Bister
Methods in Molecular Biology (Clifton, N.J.)|September 6, 2013
Analyzing Myc in cell transformation and evolutionMarkus Hartl, Klaus Bister
Methods in Molecular Biology (Clifton, N.J.)|May 21, 2021
MYC Analysis in Cancer and EvolutionMarkus Hartl, Klaus Bister
Current Topics in Microbiology and Immunology|May 4, 2017
MYC and RAF: Key Effectors in Cellular Signaling and Major Drivers in Human CancerEduard Stefan, Klaus Bister
Advances in Protein Chemistry and Structural Biology|February 21, 2018
Targeting the Architecture of Deregulated Protein Complexes in CancerEduard Stefan, Jakob Troppmair, Klaus Bister
Aging|July 19, 2015
Stopping MYC in its tracksEduard Stefan, Jonathan R Hart, Klaus Bister
Small Gtpases|December 11, 2013
Interplay of PKA and Rac: fine-tuning of Rac localization and signalingVerena A Bachmann, Klaus Bister, Eduard Stefan
Bioconjugate Chemistry|December 24, 2013
Efficient access to 3'-terminal azide-modified RNA for inverse click-labeling patternsTobias Santner, Markus Hartl, Klaus Bister, et al.
Molecular Oncology|January 17, 2020
The brain acid-soluble protein 1 (BASP1) interferes with the oncogenic capacity of MYC and its binding to calmodulinMarkus Hartl, Kane Puglisi, Andrea Nist, et al.
Virology|July 8, 2008
TOJ3, a v-jun target with intrinsic oncogenic potential, is directly regulated by Jun via a novel AP-1 binding motifAntonios I Karagiannidis, Andreas G Bader, Markus Hartl, et al.
Pageof 3